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Long-term single institution comparison of
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aneurysm repair
Brent E. Quinney, MD, Gaurav M. Parmar, MD, Shardul B. Nagre, MD, Mark Patterson, MD,
Marc A. Passman, MD, Steve Taylor, MD, James Chambers, MD, and
William D. Jordan, MD, Birmingham, Ala
Introduction: Since the development of endovascular aneurysm repair (EVAR), there remains concerns regarding its
durability, need for secondary procedures, and associated long-term morbidity. We compared these two approaches to
evaluate secondary interventions and their respective long-term durability.
Methods:All patients who had undergone endovascular and open abdominal aortic aneurysm (AAA) repair were identified
from a prospectively maintained registry. Health system charts, medical communication, and national death indexes were
reviewed. Secondary interventions were classified as vascular (aortic graft or remote) and nonvascular (incisional or
gastrointestinal).
Results: Between July 1985 and September 2009, 1908 patients underwent 1986 AAA repair procedures (EVAR 1066;
open  920). Patients were followed up to 290 months (mean 27.6  35.9) and identified with 427 surgical encounters
(EVAR 233% to 21.9%; open 194% to 21.1%). Most encounters (338% to 74.6%) were related to vascular disease: 178
(EVAR  131; open  47) related to the aortic graft; 160 (EVAR  93; open  67) were related to nonaortic vascular
disease. The remaining 89 surgical encounters included incisional hernias, small bowel obstruction, intra-abdominal
abscesses, and wound dehiscence requiring operation. Of these 89 encounters (EVAR  9; open  80), 44 patients
required surgical intervention and 36 required hospitalization without surgical procedure. Over the period of 100
months, the all-cause mortality rate was 25.2% after EVAR and 39.1% after open repair. One-year survival was 88.0% (SE
0.01) and 85.0% (SE 0.01), while 5-year survival was 58.0% (SE 0.02) and 53.0% (SE 0.02) for EVAR and open repair,
respectively (log-rank P value < .0164). Seven-year survival was 46% (SE 0.03) for EVAR and 36% (SE 0.03) for open
AAA repair.
Conclusion: EVAR requires more late secondary vascular interventions than open AAA repair, but patients who undergo
open repair have more nonvascular long-term morbidity. Long-term survival is better after EVAR compared to open
repair in this selected patient group. (J Vasc Surg 2011;54:1592-8.)
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mAbdominal aortic aneurysm (AAA) repair has changed
over the past 10 years. Conventional open AAA repair is an
established and successful operation with a small but defi-
nite mortality risk and a larger risk of some complications.
While open repair is a major procedure for the patient, its
durability and outcomes are established. Ten-year freedom
from reintervention rates range from 86% to 94%.1,2 The
majority of these interventions are graft-related with pseu-
doaneurysms, graft limb thromboses, or infection.
Endovascular aneurysm repair (EVAR), first reported
in 1991 by Parodi et al,3 was described as a minimally
invasive alternative to open AAA repair. Numerous studies
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1592ave examined the efficacy and improved short-term sur-
ival associated with EVAR. Early reports were concerning
or an increased number of reinterventions. Current esti-
ates reveal a 9% to 35% reintervention rate for EVAR over
arying time intervals with a questionable benefit in long-
erm mortality.4-11 In particular, two European random-
zed, controlled studies, Dutch Randomized Endovascular
neurysm Management (DREAM) and EVAR 1, have
hown increasing reintervention rates despite no difference
n mortality between the two procedures.4,6 Most of the
xamined reinterventions in EVAR 1 were related only to
raft complications. The randomized Open vs Endovascu-
ar Repair (OPEN) trial from the United States addressed
his concern by broadening the definition of reinterven-
ions to include small bowel obstructions, hernia repair,
nd other laparotomy induced complications. In their early
esults, the authors concluded that the reintervention rates
ere virtually identical between the two groups, unlike the
uropean trials. Additionally, the OVER trial demon-
trated similar perioperative mortality between EVAR and
pen AAA even though the European studies showed a
enefit for EVAR. In the OVER trial, the other early
enefits of EVAR were not lost at 2-years of follow-up and
ortality was not increased for endovascular patients as
emonstrated in the DREAM and EVAR 1 trials.10
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Volume 54, Number 6 Quinney et al 1593The purpose of this study was to evaluate secondary
interventions and the long-term durability of EVAR when
compared to traditional open AAA repair in a university
setting. Similar to the OVER trial, we included gastrointes-
tinal complications in our analysis of open AAA repair and
EVAR when comparing the two groups.
METHODS
Between January 1985 and September 2009, 1908
patients had 1986 AAA procedures. There were 1066
EVARs between 1999 and 2009. Similarly, 920 open AAA
repairs were performed between 1985 and 2009. Proce-
dures were entered prospectively and managed in a vascular-
specific database starting in 1994, which was continually
updated throughout a patient’s follow-up and subsequent
hospitalizations. A retrospective analysis of all EVAR and
open AAA repairs was performed. Source medical records,
medical communication, and national death indexes were
used to review patient demographics, operative character-
istics, and outcomes.
Secondary interventions were categorized as vascular or
nonvascular procedures. Vascular procedures were subdi-
vided into aorta-related, defined as a complication directly
related to graft placement, or vascular (nonaortic) reinter-
ventions. Vascular (nonaortic) procedures were those per-
formed beyond 30 days after the primary operation, in
another vascular area separate from the graft, or in a
vascular area unrelated to the primary procedure. Non-
vascular interventions were classified as gastrointestinal
(either requiring rehospitalization or reoperation) or
Table I. Patient characteristics by type of aneurysm repair
Endovascular
repair (n  1066)
Demographics n %
Age
50 years 15 1.4
51-64 years 212 19.9
65-74 years 450 42.2
75-84 years 336 31.5
85 years 48 4.5
Male gender 901 84.9
Race
African American 101 9.5
European American 952 89.8
Risk factors
Ever smoker 896 84.1
Hypertension 744 69.8
Dyslipidemia 487 45.7
Previous CABG 301 28.2
CAD 591 55.4
COPD 253 23.7
Diabetes 158 14.8
Dialysis 37 3.5
CABG, Coronary artery bypass grafting; CAD, coronary artery disease; CO
The t test used for continuous variables and 2 test used for categorical vari
aStatistical significance at alpha of .05.incisional hernia. tWe compared the characteristics and risk factor dis-
ribution of the patient groups using 2 tests for categor-
cal variables and t tests for continuous variables. Hyper-
ension, dyslipidemia, and diabetes were identified by
ecord of physician diagnosis in medical charts, or by the
ctive use of medications for any of these conditions.
atient survival rates were estimated with the use of
aplan-Meier life table methods, and comparisons were
ade with the use of Wilcoxon and log-rank analysis.
tatistical significance was set at a P value of  .05. All
tatistical analyses were conducted using SAS version 9.2
SAS Institute, Cary, NC).
ESULTS
Overall, 427 secondary interventions were performed
hich corresponds to a 22.7% reintervention rate. Most
ncounters (338% to 74.6%) were related to arterial disease:
78 (EVAR  131; open  47) related to the aortic graft
nd 160 (EVAR 93; open 67) were related to nonaor-
ic vascular disease.
The two groups were similar in race and gender. Pa-
ients in the EVAR group tended to be elderly with more
omorbidities, including coronary artery disease, hyperlip-
demia, hypertension, and diabetes mellitus than patients in
he open AAA group (Table I). Endograft selection was
riven by many factors, including availability, training,
atient’s anatomy, and surgeon’s preference. Additionally,
4 endografts were part of a phase 2 clinical study, but all
ypes are outlined in Table II.
Of the 1066 EVAR procedures performed at our insti-
1986)
Open
repair (n  920)
n % P value
18 2.0 .0001a
239 26.0
403 43.8
208 22.6
14 1.5
708 81.7 .06
87 10.6 .65
726 88.5
569 61.8 .0001a
546 59.3 .0001a
253 27.5 .0001a
217 23.6 .03a
401 43.6 .0001a
201 21.8 .4
83 9.0 .0001a
23 2.5 .23
ronic obstructive pulmonary disease.(n 
PD, chution during the study period, secondary aortic-related
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December 20111594 Quinney et algraft procedures accounted for 131 of the 233 procedures
(12.3%; Table III). The majority were transfemoral proce-
dures, including proximal cuffs (n  22; 2.1%), iliac ex-
tenders (n  36; 3.4%), and embolizations of expanding
aneurysm sac with type II endoleaks (n  19; 1.8%).
Relining of an original endograft for expansion or migra-
tion was performed in 16 cases (1.5%). Secondary aneurysm
repair that was contiguous with the initial operation
occurred in 5 patients (0.5%). Laparoscopic ligation for a
type II endoleak (n  3; 0.3%) and hypogastric artery
stenting (n  2; 0.2%) were rare. Iliac complications
done after 30 days from the primary procedure were
repaired in 4 cases (0.4%).
Twenty-one explantations (2.0%) were performed in
this series. Six patients required acute conversion with five
performed at the time of the index procedure. Fifteen
patients necessitated delayed conversion (median, 26.8
months; range, 2-88 months). Indications for delayed con-
version included: expanding aneurysm sac/endoleak (n 
7), migration with endoleak (n  3), rupture (n  3), and
infection (n  2). Of those conversions performed for
endoleaks, eight were required for type I endoleaks (5
proximal, 2 distal) with one explant for a type II endoleak
and one for a type III endoleak.
In contrast to the aortic-related procedures, patients
who had EVAR underwent 93 interventions (8.7%) that
were unrelated to the primary repair. Infrainguinal revascu-
larization was required 63 times (5.9%). A separate thoracic
aortic aneurysm (TAA) was repaired in 13 cases (1.2%).
Carotid procedures were performed in 14 patients (1.3%).
Delayed iliac artery dissection or stenosis was stented in 3
cases (0.3%).
During analysis of secondary interventions, we identi-
fied 9 patients (0.8%) requiring reintervention such as
gastrointestinal hemorrhage (n  4; 0.4%), bowel surgery
for small bowel obstruction (n  4; 0.4%), and intra-
abdominal abscess (n  1). Whereas these procedures
occurred after the primary endograft, they were not
thought to be complications directly related to the initial
procedure.
Open AAA repair was performed in 920 patients of
Table II. Types of endografts
Type Frequency (n) Percent (%)
Ancure 207 19.4
Aneurx 225 21.1
Aorfix 8 0.8
Aptus 4 0.4
Cordis 2 0.2
Custom 6 0.6
Endurant 2 0.2
Excluder 447 41.9
Powerlink 13 1.2
Talent 36 3.4
Zenith 116 10.8
Total 1066 100whom 194 patients required secondary interventions a21.1%). Forty-seven patients had aortic graft-related pro-
edures, including: graft limb occlusion (n  16; 1.7%),
roximal or distal contiguous aneurysm (n  23; 2.5%),
nd graft excision for infection (n  8; 0.9%). Vascular
rocedures not related to the aortic graft included: in-
rainguinal revascularization (n  34; 3.7%), TAA repair
n  22; 2.4%), and carotid interventions (n  11; 1.2%;
able III).
We found 80 patients in the open AAA group who
equired other nonvascular interventions (8.9%). These
nterventions were considered related to the primary pro-
edure or laparotomy to include incisional hernias (n 29;
.2%), small bowel resection/lysis of adhesions (n  8;
.9%), colon resection (n  3; 0.3%), umbilical hernia
epair (n 2; 0.2%), and wound dehiscence (n 2; 0.2%).
hirty-six patients required hospitalization for gastroin-
estinal complaints without requiring surgical interven-
ion, which often included partial small bowel obstruc-
ions with nasogastric tube placement (n  14; 1.5%),
nfection/abscess (n  9; 0.9%), gastrointestinal hemor-
hage (n  6; 0.7%), ischemic colitis (n  5; 0.5%), and
iarrhea (n  2; 0.2%).
Kaplan-Meier estimates indicated a survival advantage
or EVAR in both the short-term and long-term (Fig 1).
hroughout the duration of this series, EVAR consistently
emonstrated improved survival when compared to open
AA repair. Over the period of 100 months, the all-cause
ortality rate was 25.2% after EVAR and 39.1% after open
epair. One-year survival was 88.0% (SE 0.01) and 85.0%
SE 0.01), whereas 5-year survival was 58.0% (SE 0.02) and
3% (SE 0.02) for EVAR and open AAA repair, respec-
ively. At 7 years, EVAR survival was 46% (SE 0.03) and
pen AAA repair survival was 36% (SE 0.03). Even exami-
ation of current outcomes out to 9 years favors EVAR
log-rank, 0.0164).
ISCUSSION
EVAR is a minimally invasive alternative treatment for
AA. Early data raised concerns for its durability and some
arly critics considered it a “failed experiment.”12 The need
or continued postoperative surveillance with the possibility
f reinterventions has created a legitimate concern for its
ong-term durability. In particular, DREAM and EVAR 1
ave shown increasing reintervention rates despite no dif-
erence in mortality between EVAR and open AAA repair.
The DREAM study demonstrated statistically insignif-
cant early survival advantage which was lost after 12
onths.6 EVAR 1 reported a statistically significant early
urvival advantage, but a significantly elevated reinterven-
ion rate in the EVAR group. However, most of the exam-
ned reinterventions in EVAR 1 were related only to graft
omplications.4 Although wound and gastrointestinal
omplications are not directly related to a vascular diagno-
is, the importance of these reinterventions should be con-
idered when evaluating the long-term impact on a pa-
ient’s health.
The randomized OVER trial from the United States
ddressed this concern by considering other reinterven-
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Volume 54, Number 6 Quinney et al 1595tions such as small bowel obstructions, hernia repair, and
other laparotomy related complications. Reintervention
rates were virtually identical in the two groups, unlike
DREAM and EVAR 1. Additionally, mortality was not
shown to increase at the 2-year follow-up period.10
A recent study of EVAR vs open AAA repair in the
Medicare population again revealed lower short-term death
Table III. Secondary interventions after endovascular and
Endovascular
repair
(n  1066)
n %
Aorta related
Explant 21 2.0
Reline 16 1.5
Proximal cuff 22 2.1
Iliac extender 36 3.4
Iliac complications 4 0.4
Embolization 19 1.8
Secondary aneurysm 5 0.5
Laparoscopic ligation/
hypogastric stent
5 0.5
Other vascular (nonaortic)
LE procedure 63 5.9%
TAA repair 13 1.2%
Carotid procedure 14 1.3%
Access complications 3 0.3%
Other
GI bleed 4 0.4%
SBO/SBR 4 0.4%
Abscess 1 0.1%
GI, Gastrointestinal; LE, lower extremity; SBO, small bowel obstruction; SB
Fig 1. Kaplan-Meier plots showing survival arates and complications in patients who had EVAR. In the aong-term, they concluded that late reinterventions related
o AAAs were more common in the EVAR group, but were
alanced by the number of laparotomy related reinterven-
ions and hospitalizations after open aortic repair. Survival
dvantage of EVAR was lost after 3 years of follow-up.13
ur rate of reinterventions after EVAR is similar to current
eported rates. A recent 8-year review of EVAR byMehta et
n abdominal aortic aneurysm repair
Open
repair
(n  920)
n %
Graft excision/infection 8 0.9
Graft limb occlusion 16 1.7
Secondary aneurysm 23 2.5
LE procedure 34 3.7%
TAA repair 22 2.4%
Carotid procedure 11 1.2%
GI hospitalization 36 3.9%
Incisional hernia 29 3.2%
Bowel surgery 15 1.6%
all bowel resection; TAA, thoracic aortic aneurysm.
patients with endovascular and open repair.opel14 revealed an 18% reintervention rate for EVAR with the
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December 20111596 Quinney et almajority of the reinterventions being transfemoral proce-
dures. One fifth of patients who had EVAR (21.9%) in our
series required secondary interventions. The majority of
aortic-related procedures in the EVAR group were trans-
femoral procedures that included proximal cuffs, iliac ex-
tenders, and embolizations (Table III).
Similar to the randomized OVER trial, without inclu-
sion of gastrointestinal complications after laparotomy, our
series would show more reinterventions for the EVAR
group when compared to the open AAA repair. However,
with the addition of wound and laparotomy related com-
plications, the reintervention rates for each group were
virtually identical (21.9% EVAR; 21.1% open AAA). Her-
nias, bowel obstructions, and repeat hospitalizations with
nasogastric tube decompression were identified in a num-
ber of our patients who had open AAA repairs (Table III).
The impact on a patients’ functional status can be signifi-
cant and should not be underestimated. Any postlapa-
rotomy gastrointestinal complication resulting in surgery
or even nasogastric tube decompression, likely requires
extended hospitalizations with increased cost and patient
discomfort. Additionally, some reviews indicate functional
quality of life is reduced after open AAA repair.15 Having
other complications such as incisional hernia or small bowel
obstruction in addition to the already reduced functional
outcome of open AAA repair may favor EVAR instead of
conventional open AAA repair. These factors should be
considered when deciding between the two procedures.
Further subanalysis in our series revealed a significant
survival advantage at 1, 5, 7 and out to 9 years despite being
done more frequently for elderly patients 75 years of age
and with more comorbidities. This advantage may reflect a
more “real-world” clinical experience of EVAR rather than
what has been reported in clinical trials considering that we
have included our entire experience of patients with EVAR
that are not always eligible for clinical trials. The current
study supplements the existing published literature indicat-
ing the safety of EVAR in the elderly.16 More asymptom-
atic aneurysm repairs are being offered to older patients due
to the increased availability of EVAR. Also, our survival
advantage could be a result of increased patients’ encoun-
ters with more imaging (ultrasound or computed tomog-
raphy [CT] scans) that may provide early diagnoses of some
other pathology not related to the aneurysm disease. Be-
cause our study was not designed to classify these other
nonvascular evaluations and management, we cannot be
certain that the improved survival was related to healthier
patients (unlikely), early diagnosis of other disease, or the
reduced physiological stress of the EVAR compared to
open AAA repair. Additionally, this study did not look
specifically at anatomic criteria that pushed patients from
EVAR to open aneurysm repair. We acknowledge that
anatomic factors could have impacted mortality in the open
group. Obviously, our results are a continuation of knowl-
edge and lessons learned from the early reports of EVAR.
Further analysis of EVAR can help identify those patients at
risk for subsequent procedures. pEarly experiences with EVAR were included in this
tudy to demonstrate the learning curve of endovascular
echniques and repair. We had no EVAR experience at our
nstitution before 1999. However, we were more conser-
ative initially in adhering to instructions for use (IFU) for
he endografts. We found little change in operative mortal-
ty over the 10-year course of the study, yet we became
ore aggressive as experience grew. There was likely a
alance in treatment and experience bias of the study due to
hese factors. Regardless, all cases were included for greater
alidity. Fig 2 demonstrates the proportions of EVAR vs
pen repair performed at our institution between the years
000 and 2009.
Study limitations included this being a retrospective
nalysis. Documentation of nonvascular complications
rom a vascular registry and database required additional
esearch. The number of gastrointestinal procedures and
ound complications is likely underreported in our series
ue to our vascular-specific practice. We identified compli-
ations only through our medical communications with
atients, referring doctors, or if they were treated at our
nstitution. Potentially, many other patients were treated at
utside facilities without our knowledge. While the etiol-
gy for gastrointestinal complications and procedures is not
lways certain, prior laparotomy with aortic reconstruction
nd subsequent adhesion formation should be considered.
here is morbidity in performing a laparotomy and these
omplications are considered in our analysis. Other limita-
ions with this study are the nonrandomization of patients
nd the fact that risk factors were not evenly matched in our
roups. However, our patients who underwent EVARwere
lder and carried more risk factors as considered in the
atient demographic analysis of most vascular studies (Ta-
le I). Further studies should consider demographic factors
uch as age, gender, and race and match each group to
ompare outcomes. Also, further subgroup analyses should
valuate whether survival is impacted by those patients that
equire reintervention and if there are preoperative ana-
omic characteristics which could predict higher secondary
Fig 2. Type of operation.rocedure rates or mortality.
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Volume 54, Number 6 Quinney et al 1597Overall, we conclude that EVAR is a safe and effective
method of treating AAA with improved survival over open
AAA repair. Patients who had EVAR required more vascu-
lar procedures related to the aortic graft when compared to
the open AAA repair group. However, the majority of these
procedures was transfemoral and minimally invasive. The
open AAA repair group had fewer graft-related proce-
dures in follow-up. However, open repair resulted in
more nonvascular interventions mostly related to wound
or intra-abdominal complications. While further research
and technological advances may decrease the secondary
interventions after EVAR, complications from nonvascular
causes in the open group present a significant impact for
patient outcomes and long-term health cost. Finally, due to
advances in endografts and operator familiarity, mortality
for EVAR has remained superior to open AAA repair in our
series. Despite reports from earlier literature of higher
reintervention rates for EVAR, we report similar secondary
intervention rates between EVAR and open AAA and also
demonstrate better short-term and long-term survival after
EVAR.
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Dr Karthikeshwar Kasirajian, (Atlanta, Ga). I thank the
authors for getting me the manuscript well ahead of time.
Over a 24-year period, the authors evaluated vascular and
nonvascular complications in patients undergoing open or endo-
vascular aneurysm repair (EVAR) for abdominal aortic aneurysms
(AAAs). Both groups included close to 1000 patients, making this
one of the largest series reported. Although the study period
started in 1985, EVAR was only incorporated in their practice in
1999. Despite significantly higher levels of comorbidities in the
EVAR group, advances over the last decade in anesthesia and
perioperative care, the use of statins, -blockers, and antiplatelet
agents may bias outcomes in favor of the EVAR group. The
authors concluded that patients who had EVAR required more
secondary aneurysm-related reinterventions, but this was offset by
the higher incidence of nonvascular reinterventions required in theI have a few comments and questions for the authors.
. Delayed iliac artery dissection/stenosis that required stenting
was classified as not related to the EVAR procedures. These will
most likely need to be reclassified as EVAR-related, as angio-
plasty and sheath-related trauma to the iliac vessels can cause
delayed iliac lesions.
. Gastrointestinal complications after EVAR (eg, hemorrhage/
small bowel obstruction) was classified as non-EVAR related.
Once again, these probably need to be reclassified, as acute loss
of the inferior mesenteric artery, internal iliac, superior mesen-
teric artery embolization has been reported to cause gastroin-
testinal hemorrhage, bowel ischemia, or bowel obstruction.
The time for these events, if close to the EVAR repair, is more
suggestive of relation to the aneurysm repair.
. What percentage of patients in the open and EVAR groups have
been lost to follow-up? As the mean follow-up was 27 months,
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December 20111598 Quinney et aland traditionally open repairs do not get close follow-up, a
higher loss to follow-up in one group may bias the study.
4. Did patients who had an open repair get a CT scan at 3 or 5
years post-treatment? Some studies have reported a 15% inci-
dence of anastomotic aneurysm at 5 years in this patient popu-
lation.
5. What percentage of open repairs used a retroperitoneal vs a
midline approach? Do the authors think the incidence of gas-
trointestinal complications would be different between these
approaches?
6. What percentage of patients in an open repair had a prior
peritoneal intervention (ie, open appendectomy, hysterectomy)
before the open repair? This may be related to the subsequent
bowel obstruction, or other complication.
7. Despite what seems to be slight bias to make EVAR data seem
better, the authors have made a strong case that seems to favor
EVAR vs open repair. Given the substantial experience at your
center,whatwould be the preferred approach to a healthy 55-year-
old male patient presenting with an anatomically suitable AAA?
(The patient wants the physician to make the decision!)
Dr Brenton E. Quinney. Thank you, Dr Kasirajian, for your
review of the article and the presentation. First, iliac artery dissec-
tion or stenosis that required stenting occurred outside of 30 days,
was not contiguous with the original graft, and therefore was not
included in the graft-related complications. The time interval and
noninvolvement of the endograft made inclusion in the nongraft-
related complications more logical.
Gastrointestinal complications from the EVAR group were
also outside of 30 days and placed in the nonvascular category. Due
to the time interval, we concluded that these complications were
not related to primary graft placement.
From our review of EVAR that was presented at the Society for
Vascular Surgery in Boston in June 2010, 1.5% of our patients were aost to follow-up. In this review,we found slightly over 10%of patients
n the open group who were lost to follow-up. Themean time period
f follow-up for these groups was 27 months. Our data obviously
ould be biased by some of our open patients who followed-up 1 or 2
ears after their initial repair and then never returned.
Surveillance for patients requiring open repair of their aneu-
ysm was usually by CT scanning at 3 or 5 years postoperatively
epending on the anatomy of the proximal neck based upon the
irection of the operating surgeon. A difficult or anatomically
ostile neck necessitated CT scan surveillance at the earlier 3-year
eriod.
Our series included very few retroperitoneal approaches as the
nitial repair. Most patients in our series undergo transperitoneal
epair. We agree that there is a possibility of having fewer gastro-
ntestinal complications by using a retroperitoneal approach rather
han transperitoneal but we also believe that our practice is more
ypical of the general population who tend to use transperitoneal
pproach rather than the retro-peritoneal approach.
There is not an exact number of patients that we identified as
aving prior peritoneal interventions before aneurysm repair.
hile a patient with multiple previous laparotomies may bias us
oward an EVAR, most often our decision for EVAR was based
pon anatomy of the aorta rather than the status of the abdomen.
single prior laparotomy was not a bias toward EVAR one way or
he other.
Finally, your last question involves a 55-year-old man with
uitable anatomy for EVAR who desires his physician to make the
ecision (EVAR vs open). From our review presented here, we
ould recommend EVAR for this patient with suitable anatomy.
hile the reintervention rate was similar between open and EVAR,
hemajority of reinterventions in our patients who had EVARwere
inimally invasive transfemoral procedures of which the patients
re quite tolerant.
